The multifaceted oncogene SND1 in cancer: focus on hepatocellular carcinoma

Abstract

Staphylococcal nuclease and tudor domain containing 1 (SND1) is a protein that regulates a complex array of functions. It controls gene expression through transcriptional activation, mRNA degradation, mRNA stabilization, ubiquitination and alternative splicing. More than two decades of research has accumulated evidence of the role of SND1 as an oncogene in various cancers. It is a promoter of cancer hallmarks like proliferation, invasion, migration, angiogenesis and metastasis. In addition to these functions, it has a role in lipid metabolism, inflammation and stress response. The participation of SND1 in such varied functions makes it distinct from most oncogenes that are relatively more focused in their role. This becomes important in the case of hepatocellular carcinoma (HCC) since in addition to typical cancer drivers, factors like lipid metabolism deregulation and chronic inflammation can predispose hepatocytes to HCC. The objective of this review is to provide a summary of the current knowledge available on SND1, specifically in relation to HCC and to shed light on its prospect as a therapeutic target.

Keywords

Staphylococcal nuclease and tudor domain containing 1 / hepatocellular carcinoma / inflammation

References

[1] Sanyal AJ,Lencioni R.The etiology of hepatocellular carcinoma and consequences for treatment.Oncologist2010;14-22

[2] El-Serag HB.Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go?.Hepatology2014;60:1767-75 PMCID:PMC4211957

[3] Llovet JM,Mazzaferro V,Gane E,de Oliveira AC,Raoul JL,Schwartz M,Zeuzem S,Greten TF,Seitz JF,Haussinger D,Shan M,Voliotis D,SHARP Investigators Study Group..Sorafenib in advanced hepatocellular carcinoma.N Engl J Med2008;359:378-90

[4] Tovoli F,De Lorenzo S.Regorafenib for the treatment of hepatocellular carcinoma.Drugs Today (Barc)2018;54:5-13

[5] Sun W.Systemic treatment of patients with advanced, unresectable hepatocellular carcinoma: emergence of therapies.J Gastrointest Cancer2018;49:107-15 PMCID:PMC5948236

[6] Di Costanzo GG,Marisi G,Scartozzi M,Faloppi L,Silvestris N,Palmieri VO,Tortora R.Validation of a simple scoring system to predict sorafenib effectiveness in patients with hepatocellular carcinoma.Target Oncol2017;12:795-803

[7] El-Khoueiry AB,Yau T,Kudo M,Kim TY,Trojan J,Meyer T,Yeo W,Anderson J,Lang L,Tang H,Melero I.Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial.Lancet2017;389:2492-502

[8] Tong X,Yalamanchili R,Kieff E.The Epstein-Barr virus nuclear protein 2 acidic domain forms a complex with a novel cellular coactivator that can interact with TFIIE.Mol Cell Biol1995;15:4735-44 PMCID:PMC230717

[9] Callebaut I.The human EBNA-2 coactivator p100: multidomain organization and relationship to the staphylococcal nuclease fold and to the tudor protein involved in Drosophila melanogaster development.Biochem J1997;321:125-32 PMCID:PMC1218045

[10] Broadhurst MK,Hawkins S.The p100 EBNA-2 coactivator: a highly conserved protein found in a range of exocrine and endocrine cells and tissues in cattle.Biochim Biophys Acta2005;1681:126-33

[11] Abe S,Takahashi F.Structural analysis of cDNAs coding for 4SNc-Tudor domain protein from fish and their expression in yellowtail organs.Mar Biotechnol (NY)2005;7:677-86

[12] Howard-Till RA.Tudor nuclease genes and programmed DNA rearrangements in Tetrahymena thermophila.Eukaryot Cell2007;6:1795-804 PMCID:PMC2043382

[13] Armengol S,Rodriguez L,Chico Y.NF-kappaB, Sp1 and NF-Y as transcriptional regulators of human SND1 gene.Biochimie2013;95:735-42

[14] Rodriguez L,Ochoa B.Isolation and characterization of the rat SND p102 gene promoter: putative role for nuclear factor-Y in regulation of transcription.Ann N Y Acad Sci2006;1091:282-95

[15] Rodriguez L,Martinez MJ.NF-Y and Sp1 are involved in transcriptional regulation of rat SND p102 gene.Biochem Biophys Res Commun2007;356:226-32

[16] Armengol S,Enzunza L,Mendibil U,Ochoa B,Martinez MJ.SREBP-2-driven transcriptional activation of human SND1 oncogene.Oncotarget2017;8:108181-94 PMCID:PMC5746135

[17] Yu L,Cui K,Xin L,Zhang W,Wei M,Yang J.SND1 acts downstream of TGFbeta1 and upstream of Smurf1 to promote breast cancer metastasis.Cancer Res2015;75:1275-86

[18] Yang J,Pesu M,Saarinen J,Kieff E.Identification of p100 as a coactivator for STAT6 that bridges STAT6 with RNA polymerase II.EMBO J2002;21:4950-8 PMCID:PMC126276

[19] Paukku K,Silvennoinen O.Tudor and nuclease-like domains containing protein p100 function as coactivators for signal transducer and activator of transcription 5.Mol Endocrinol2003;17:1805-14

[20] Leverson JD,Orrico FC,Jalkanen KJ,Eisenman RN.Pim-1 kinase and p100 cooperate to enhance c-Myb activity.Mol Cell1998;2:417-25

[21] Yang J,Hong J,Yao Z,Frilander MJ.Transcriptional co-activator protein p100 interacts with snRNP proteins and facilitates the assembly of the spliceosome.Nucleic Acids Res2007;35:4485-94 PMCID:PMC1935017

[22] Paukku K,Silvennoinen O,Lehtonen JY.p100 increases AT1R expression through interaction with AT1R 3'-UTR.Nucleic Acids Res2008;36:4474-87 PMCID:PMC2490763

[23] Caudy AA,Hammond SM,Bathoorn AM,Silva JM,Hannon GJ.A micrococcal nuclease homologue in RNAi effector complexes.Nature2003;425:411-4

[24] Hanahan D.Hallmarks of cancer: the next generation.Cell2011;144:646-74

[25] Jariwala N,Srivastava J,Akiel MA,Emdad L,Sarkar D.Role of the staphylococcal nuclease and tudor domain containing 1 in oncogenesis (review).Int J Oncol2015;46:465-73 PMCID:PMC4277250

[26] Valineva T,Palovuori R.The transcriptional co-activator protein p100 recruits histone acetyltransferase activity to STAT6 and mediates interaction between the CREB-binding protein and STAT6.J Biol Chem2005;280:14989-96

[27] Duan Z,Fu X,Xin L,Yang X,Silvennoinen O,Yang J.Tudor-SN, a novel coactivator of peroxisome proliferator-activated receptor gamma protein, is essential for adipogenesis.J Biol Chem2014;289:8364-74 PMCID:PMC3961662

[28] Su C,Tecle A,He J,Zhang W,Ren Y,Yao Z,Wei M.Tudor staphylococcal nuclease (Tudor-SN), a novel regulator facilitating G1/S phase transition, acting as a co-activator of E2F-1 in cell cycle regulation.J Biol Chem2015;290:7208-20 PMCID:PMC4358140

[29] Cappellari M,Paronetto MP,Fimia GM,Silvennoinen O.The transcriptional co-activator SND1 is a novel regulator of alternative splicing in prostate cancer cells.Oncogene2014;33:3794-802

[30] Elbarbary RA,Myers JR,Ashton JM,Maquat LE.Tudor-SN-mediated endonucleolytic decay of human cell microRNAs promotes G1/S phase transition.Science2017;356:859-62 PMCID:PMC5551500

[31] Xing A,Gao J.p100 functions as a metastasis activator and is targeted by tumor suppressing microRNA-320a in lung cancer.Thorac Cancer2018;9:152-8 PMCID:PMC5754290

[32] Ma F,Guo B,Zheng Y,Wu Y,Sha R,Wang D,Li J.MiR-361-5p inhibits colorectal and gastric cancer growth and metastasis by targeting staphylococcal nuclease domain containing-1.Oncotarget2015;6:17404-16 PMCID:PMC4627317

[33] Emdad L,Alzubi MA,Santhekadur PK,Shen XN,Sarkar D.Suppression of miR-184 in malignant gliomas upregulates SND1 and promotes tumor aggressiveness.Neuro Oncol2015;17:419-29 PMCID:PMC4483100

[34] Yu L,Xin L,Liu X,Zhang W,Yang J.SND1 acts as a novel gene transcription activator recognizing the conserved Motif domains of Smad promoters, inducing TGFbeta1 response and breast cancer metastasis.Oncogene2017;36:3903-14

[35] Chmielecki J,Frampton GM,Johnson A,Elvin J,Ross JS,Balasubramanian S,Yelensky R,Miller VA,Stephens PJ.Comprehensive genomic profiling of pancreatic acinar cell carcinomas identifies recurrent RAF fusions and frequent inactivation of DNA repair genes.Cancer Discov2014;4:1398-405

[36] Dillon R,Shi SD,Krastins B.Discovery of a novel B-Raf fusion protein related to c-Met drug resistance.J Proteome Res2011;10:5084-94

[37] Jang JS,Li J,Yang Y,Asmann YW,Erickson-Johnson M,Sun Z,Hwang H,Edell ES,Kopp KJ,Oliveira AM,Aubry MC,Wigle D,Yang P.Common oncogene mutations and novel SND1-BRAF transcript fusion in lung adenocarcinoma from never smokers.Sci Rep2015;5:9755 PMCID:PMC4434945

[38] Yoo BK,Gredler R,Emdad L,Pannell L,Sarkar D.Increased RNA-induced silencing complex (RISC) activity contributes to hepatocellular carcinoma.Hepatology2011;53:1538-48 PMCID:PMC3081619

[39] Santhekadur PK,Emdad L,Srivastava J,Robertson CL,Fisher PB.Staphylococcal nuclease domain containing-1 (SND1) promotes migration and invasion via angiotensin II type 1 receptor (AT1R) and TGFbeta signaling.FEBS Open Bio2014;4:353-61 PMCID:PMC4050181

[40] Santhekadur PK,Gredler R,Srivastava J,Baldwin ASJr,Sarkar D.Multifunction protein staphylococcal nuclease domain containing 1 (SND1) promotes tumor angiogenesis in human hepatocellular carcinoma through novel pathway that involves nuclear factor kappaB and miR-221.J Biol Chem2012;287:13952-8 PMCID:PMC3340184

[41] Rajasekaran D,Mendoza RG,Akiel MA,Fisher PB.Staphylococcal nuclease and tudor domain containing 1 (SND1 protein) promotes hepatocarcinogenesis by inhibiting monoglyceride lipase (MGLL).J Biol Chem2016;291:10736-46 PMCID:PMC4865920

[42] Yin J,Huang L,Shi X,Song J,Gao X,Jing X.SND1 affects proliferation of hepatocellular carcinoma cell line SMMC-7721 by regulating IGFBP3 expression.Anat Rec (Hoboken)2013;296:1568-75

[43] Jariwala N,Mendoza RG,Siddiq A,Robertson CL,Windle JJ,Sanyal AJ.Oncogenic role of SND1 in development and progression of hepatocellular carcinoma.Cancer Res2017;77:3306-16 PMCID:PMC5488274

[44] Bishayee A.The role of inflammation and liver cancer.Adv Exp Med Biol2014;816:401-35

[45] Cholankeril G,Khurana S.Hepatocellular carcinoma in non-alcoholic steatohepatitis: current knowledge and implications for management.World J Hepatol2017;9:533-43 PMCID:PMC5395802

[46] Farrell GC,Gan L.NASH is an inflammatory disorder: pathogenic, prognostic and therapeutic implications.Gut Liver2012;6:149-71 PMCID:PMC3343154

[47] Weissbach R.Tudor-SN and ADAR1 are components of cytoplasmic stress granules.RNA2012;18:462-71 PMCID:PMC3285934

[48] Su C,Yang W,Fu X,Zhang C,Ren Y,Shui W,Wei M.Phosphorylation of Tudor-SN, a novel substrate of JNK, is involved in the efficient recruitment of Tudor-SN into stress granules.Biochim Biophys Acta2017;1864:562-71

[49] Puri P,Cheung O,Maher JW,Sanyal AJ.Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease.Gastroenterology2008;134:568-76

[50] Armengol S,Enzunza L,Ochoa B,Martinez MJ.The promoter of cell growth- and RNA protection-associated SND1 gene is activated by endoplasmic reticulum stress in human hepatoma cells.BMC Biochem2014;15:25 PMCID:PMC4266219

[51] Fu X,Meng H,Shi L,Wang Y,Xin L,Zhang W,Ge L,Yao Z,Yang J.Oncoprotein Tudor-SN is a key determinant providing survival advantage under DNA damaging stress.Cell Death Differ2018;

[52] Baenke F,Miess H.Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development.Dis Model Mech2013;6:1353-63 PMCID:PMC3820259

[53] Straub BK,Singer S,Breuhahn K,Warth A,Longerich T,Schirmacher P.Lipid droplet-associated PAT-proteins show frequent and differential expression in neoplastic steatogenesis.Mod Pathol2010;23:480-92

[54] Keenan TW,Rackwitz HR.Nuclear coactivator protein p100 is present in endoplasmic reticulum and lipid droplets of milk secreting cells.Biochim Biophys Acta2000;1523:84-90

[55] Garcia-Arcos I,Gonzalez-Kother P,Ochoa B.Association of SND1 protein to low density lipid droplets in liver steatosis.J Physiol Biochem2010;66:73-83

[56] Palacios L,Gomez-Lechon MJ,Fresnedo O.Overexpression of SND p102, a rat homologue of p100 coactivator, promotes the secretion of lipoprotein phospholipids in primary hepatocytes.Biochim Biophys Acta2006;1761:698-708

[57] Navarro-Imaz H,Fresnedo O.SND1 overexpression deregulates cholesterol homeostasis in hepatocellular carcinoma.Biochim Biophys Acta2016;1861:988-96

[58] Arretxe E,Mula S,Ochoa B.Profiling of promoter occupancy by the SND1 transcriptional coactivator identifies downstream glycerolipid metabolic genes involved in TNFalpha response in human hepatoma cells.Nucleic Acids Res2015;43:10673-88 PMCID:PMC4678849